You have free access to this content

Pharmacoepidemiology and Drug Safety

© John Wiley & Sons, Ltd.

Cover image for Vol. 21 Issue S2

Supplement: Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research

May 2012

Volume 21, Issue Supplement S2

Pages 1–154

Issue edited by: Sebastian Schneeweiss, Scott R. Smith

  1. Editorials

    1. Top of page
    2. Editorials
    3. Commentaries
    4. Original Reports
    1. You have free access to this content
      Methods for developing and analyzing clinically rich data for patient-centered outcomes research: an overview (pages 1–5)

      Sebastian Schneeweiss, John D. Seeger and Scott R. Smith

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3270

  2. Commentaries

    1. Top of page
    2. Editorials
    3. Commentaries
    4. Original Reports
    1. You have free access to this content
      When to randomize, or ‘Evidence-based medicine needs Medicine-based evidence’ (pages 6–12)

      John Concato

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3245

  3. Original Reports

    1. Top of page
    2. Editorials
    3. Commentaries
    4. Original Reports
    1. You have free access to this content
      Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics (pages 13–20)

      Sengwee Toh, Luis A. García Rodríguez and Miguel A. Hernán

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3248

    2. You have free access to this content
      Identification of metastatic cancer in claims data (pages 21–28)

      Beth L. Nordstrom, Joanna L. Whyte, Marilyn Stolar, Catherine Mercaldi and Joel D. Kallich

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3247

    3. You have free access to this content
      Linkage of routinely collected oncology clinical data with health insurance claims data—an example with aromatase inhibitors, tamoxifen, and all-cause mortality (pages 29–36)

      David D. Dore, Caihua Liang, Najat Ziyadeh, Heather Norman, Martha Bayliss and John D. Seeger

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3244

    4. You have free access to this content
      Merging of the National Cancer Institute–funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group (pages 37–43)

      R. Aplenc, B. T. Fisher, Y. S. Huang, Y. Li, T. A. Alonzo, R. B. Gerbing, M. Hall, D. Bertoch, R. Keren, A. E. Seif, L. Sung, P. C. Adamson and A. Gamis

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3241

    5. You have free access to this content
      Incorporating initial treatments improves performance of a mortality prediction model for patients with sepsis (pages 44–52)

      Tara Lagu, Michael B. Rothberg, Brian H. Nathanson, Jay S. Steingrub and Peter K. Lindenauer

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3229

    6. You have free access to this content
      Evaluation of total hip arthroplasty devices using a total joint replacement registry (pages 53–59)

      Elizabeth W. Paxton, Christopher F. Ake, Maria C.S. Inacio, Monti Khatod, Danica Marinac-Dabic and Art Sedrakyan

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3228

    7. You have free access to this content
      Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies (pages 60–68)

      Menggang Yu, Dawei Xie, Xingmei Wang, Mark G. Weiner and Richard L. Tannen

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3235

    8. You have free access to this content
      One-to-many propensity score matching in cohort studies (pages 69–80)

      Jeremy A. Rassen, Abhi A. Shelat, Jessica Myers, Robert J. Glynn, Kenneth J. Rothman and Sebastian Schneeweiss

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3263

    9. You have free access to this content
      Performance of propensity score methods when comparison groups originate from different data sources (pages 81–89)

      Bradley G. Hammill, Lesley H. Curtis and Soko Setoguchi

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3251

    10. You have free access to this content
      Confronting “confounding by health system use” in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment (pages 90–98)

      Jennifer M. Polinski, Sebastian Schneeweiss, Robert J. Glynn, Joyce Lii and Jeremy A. Rassen

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3250

    11. You have free access to this content
      Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes (pages 99–113)

      Romain Neugebauer, Bruce Fireman, Jason A. Roy, Patrick J. O'Connor and Joe V. Selby

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3253

      Corrected by:

      Erratum: Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes

      Vol. 21, Issue 12, 1361, Article first published online: 6 DEC 2012

    12. You have free access to this content
      Simulation study of instrumental variable approaches with an application to a study of the antidiabetic effect of bezafibrate (pages 114–120)

      Bing Cai, Sean Hennessy, James H. Flory, Daohang Sha, Thomas R. Ten Have and Dylan S. Small

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3252

    13. You have free access to this content
      Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect (pages 121–129)

      Carlos O. Weiss, Jodi B. Segal and Ravi Varadhan

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3242

    14. You have free access to this content
      Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder (pages 130–137)

      James Signorovitch, M. Haim Erder, Jipan Xie, Vanja Sikirica, Mei Lu, Paul S. Hodgkins and Eric Q. Wu

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3246

    15. You have free access to this content
      Role of disease risk scores in comparative effectiveness research with emerging therapies (pages 138–147)

      Robert J. Glynn, Joshua J. Gagne and Sebastian Schneeweiss

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3231

    16. You have free access to this content
      Reweighted Mahalanobis distance matching for cluster-randomized trials with missing data (pages 148–154)

      Robert A. Greevy Jr., Carlos G. Grijalva, Christianne L. Roumie, Cole Beck, Adriana M. Hung, Harvey J. Murff, Xulei Liu and Marie R. Griffin

      Article first published online: 3 MAY 2012 | DOI: 10.1002/pds.3260

SEARCH

SEARCH BY CITATION